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THE ADAPTIVE response of the immune system. leading to immunity or to nonreactivity. and fre-
quently to gradations hetween these extremes. is deter-
mined primarily hy antigen migration and localization. in 
contradistinction to antigen per se. 1 This conclusion has 
been determined through separate lines of evidencl:. Thl: 
first began in 1992 with the previously overlooked finding of 
donor leukocyte chimerism in organ transplant recipients.' 
The second came from ohservations following experimental 
infections. with emphasis on the importancl: of the trans-
port and localization of live microhial antigen (viral. hacte-
rial. and protozoan)' 
In both circumstances. there arc two potential mecha-
nisms of nonresponsive ness: (I) clonal exhaustion/deletion 
and (2) immune imlifference. The kinetics of the migratory 
antigen leading on average to acute immune reactivity or to 
immune indifference at one extreme and exhaustion/dele-
tion at the other are intluenced by dose. timing. route. and 
localization of the migratlHY antigen. Although thc relation 
between infectious and transplantation immunity is compli-
cated hy the presence of a double immune reaction after 
transplantation (host-versus-graft and graft-vcrs us-host ) 
and the additional factor of immunosuppression. the t\VO 
mechanisms of acquired tolerance and the rules by which 
they operate are fundamentally the same. 
This concept exposes the meaning of acquired immuno-
logic tolerance as first produced in a transplant setting 44 
years ago by Billingham. Brent. and Medawar. and it relatcs 
such tolerance to the "allograft acceptance" that we observe 
daily in practice. The enigmatic pattern of immunologic 
confrontation and resolution seen in organ recipients was 
explained by responses of co-existing donor and recipient 
immune cells. each to the other. causing rcciprocal clonal 
expansion, followed by peripheral clonal deletion. U An 
additional role of immune indifference was suggested by the 
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replacement of donor hv rccipicnt leukocytes in the tran~­
planted organ (rendering the graft less antigenic) and hy 
uhiquitous di,trihution of the migratory donor leukocytes in 
the skin. host parenchymal organs, and other non lymphoid 
areas where they may he sequestered from cytotoxic T 
lymphocytes and neutraliZing antibodic,. 
Increasingly potent hasclinc immune suppres,ants have 
allowed these changes Il1 the hosl!gratt relationship to bl' 
engineered more etliciently and safely. This has been re-
fkcted in a -,tep\'\ ISl' imrrmement of patient and graft 
survival-from zero to feasihle hut unsatisfactory with 
azathioprine. ,triking imrrovement with the advent ()f 
cyclosporine A (C\:\). and another dramatic one with FK 
:;06. Thesc Im[HO\emcllts. made possihle with hettcr drugs. 
have been ohsCfVL'l1 with ;t\1 wh()le urgan transplantation 
and with bOIl(: m;lrnl\,\ transplantation. Becausc FK 5()() can 
efficiently rcscuc thl' \'a\! majoritv of CyA failurcs. the 
availability of FK 5()1l h;IS systematically upgraded program 
performance cvcn \\ hcn It has not hccn used from the 
outset as the hasclinc Immunosuppressant:' 
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